Bone Marrow TransplantationHematologic DiseasesAnemia, Sickle CellBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyKidney TransplantationRecurrenceMice, Inbred C57BLHematopoiesisTreatment OutcomeTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationRemission InductionImmunosuppressive AgentsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisTransplantation ImmunologyLeukemia, MyeloidRetrospective StudiesGraft vs Host ReactionImmunosuppressionStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte DepletionAcute DiseaseLeukocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsHeart TransplantationT-LymphocytesColony-Forming Units AssaySevere Combined ImmunodeficiencyFollow-Up StudiesChimeraSurvival RateHLA AntigensMyelodysplastic SyndromesFlow CytometryBreast NeoplasmsLung TransplantationMice, Inbred BALB CActuarial AnalysisCyclosporineCell ProliferationCell DifferentiationBone DensityAntineoplastic AgentsLymphocyte TransfusionDisease-Free SurvivalPrognosisNeoplasmsNuclear FamilyCarmustineOrgan TransplantationPancytopeniaApoptosisEtoposideGraft vs Tumor EffectCytarabineLeukocyte CountCells, CulturedGraft vs Leukemia EffectCell Line, TumorCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorBone NeoplasmsSpleenLymphomaBone ResorptionMelphalanAntibodies, Monoclonal